Detailed information for compound 459269

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 403.517 | Formula: C25H29N3O2
  • H donors: 0 H acceptors: 2 LogP: 4.66 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCN(C(Cc1ccccc1)(C#Cc1ncnc2c1cc(OC)c(c2)OC)C)CC
  • InChi: 1S/C25H29N3O2/c1-6-28(7-2)25(3,17-19-11-9-8-10-12-19)14-13-21-20-15-23(29-4)24(30-5)16-22(20)27-18-26-21/h8-12,15-16,18H,6-7,17H2,1-5H3
  • InChiKey: BBMKJPDKBXILOP-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni protein-s-isoprenylcysteine o-methyltransferase 0.3403 1 1
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0123 0.0245 0.0484
Schistosoma mansoni tyrosine kinase 0.0058 0.0049 0.0049
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0137 0.0286 1
Brugia malayi hypothetical protein 0.2648 0.7754 0.7754
Trypanosoma brucei Prostaglandin E synthase 0.2648 0.7754 0.7746
Trypanosoma cruzi glutathione-S-transferase/glutaredoxin, putative 0.2648 0.7754 0.7746
Mycobacterium tuberculosis Probable dehydrogenase 0.0123 0.0245 0.0484
Schistosoma mansoni tyrosine kinase 0.0097 0.0165 0.0165
Mycobacterium ulcerans hypothetical protein 0.1486 0.4297 0.5
Schistosoma mansoni tyrosine kinase 0.0058 0.0049 0.0049
Echinococcus multilocularis 0.0056 0.0043 0.0043
Echinococcus granulosus epidermal growth factor receptor 0.018 0.0413 0.0413
Plasmodium falciparum protein-S-isoprenylcysteine O-methyltransferase, putative 0.3403 1 1
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0123 0.0245 0.0484
Echinococcus multilocularis 0.3403 1 1
Trypanosoma cruzi glutathione-S-transferase/glutaredoxin, putative 0.2648 0.7754 0.7746
Echinococcus granulosus epidermal growth factor receptor 0.0097 0.0165 0.0165
Schistosoma mansoni tyrosine kinase 0.0097 0.0165 0.0165
Loa Loa (eye worm) hypothetical protein 0.2648 0.7754 0.7746
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0123 0.0245 0.0484
Echinococcus multilocularis thioredoxin glutathione reductase 0.0054 0.0038 0.0038
Echinococcus granulosus melanoma receptor tyrosine protein kinase 0.0097 0.0165 0.0165
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0137 0.0286 0.058
Trypanosoma cruzi prenyl protein specific carboxyl methyltransferase, putative 0.3403 1 1
Trypanosoma cruzi prenyl protein specific carboxyl methyltransferase, putative 0.3403 1 1
Brugia malayi glutathione reductase 0.0054 0.0038 0.0038
Echinococcus granulosus insulin growth factor 1 receptor beta 0.0058 0.0049 0.0049
Schistosoma mansoni tyrosine kinase 0.018 0.0413 0.0413
Mycobacterium tuberculosis Probable reductase 0.0123 0.0245 0.0484
Schistosoma mansoni tyrosine kinase 0.0096 0.0162 0.0162
Trichomonas vaginalis protein-S isoprenylcysteine O-methyltransferase, putative 0.3403 1 0.5
Giardia lamblia Isoprenylcysteine carboxyl methyltransferase 0.3403 1 0.5
Trichomonas vaginalis protein-S isoprenylcysteine O-methyltransferase, putative 0.3403 1 0.5
Leishmania major prenyl protein specific carboxyl methyltransferase, putative 0.3403 1 1
Brugia malayi Protein kinase domain containing protein 0.0058 0.0049 0.0049
Plasmodium vivax protein-S-isoprenylcysteine O-methyltransferase, putative 0.3403 1 1
Entamoeba histolytica prenyl cysteine carboxyl methyltransferase, putative 0.3403 1 1
Echinococcus granulosus protein S isoprenylcysteine O methyltransferase 0.3403 1 1
Brugia malayi Thioredoxin reductase 0.0054 0.0038 0.0038
Echinococcus multilocularis insulin growth factor 1 receptor beta 0.0058 0.0049 0.0049
Schistosoma mansoni tyrosine kinase 0.0096 0.0162 0.0162
Mycobacterium tuberculosis Probable oxidoreductase 0.0137 0.0286 0.058
Echinococcus granulosus thioredoxin glutathione reductase 0.0054 0.0038 0.0038
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0137 0.0286 0.058
Loa Loa (eye worm) protein-S isoprenylcysteine O-methyltransferase 0.3403 1 1
Trichomonas vaginalis protein-S isoprenylcysteine O-methyltransferase, putative 0.3403 1 0.5
Mycobacterium tuberculosis Conserved hypothetical membrane protein 0.1486 0.4297 1
Loa Loa (eye worm) TK/INSR protein kinase 0.0058 0.0049 0.001
Toxoplasma gondii isoprenylcysteine carboxyl methyltransferase (icmt) family protein 0.3403 1 1
Echinococcus multilocularis insulin receptor 0.0058 0.0049 0.0049
Loa Loa (eye worm) TK/EGFR protein kinase 0.018 0.0413 0.0376
Leishmania major glutathione-S-transferase/glutaredoxin, putative 0.2648 0.7754 0.7746
Entamoeba histolytica prenyl cysteine carboxyl methyltransferase, putative 0.3403 1 1
Onchocerca volvulus 0.2648 0.7754 0.5
Echinococcus granulosus insulin receptor 0.0058 0.0049 0.0049
Echinococcus multilocularis epidermal growth factor receptor 0.018 0.0413 0.0413
Trypanosoma brucei prenyl protein specific carboxyl methyltransferase 0.3403 1 1
Echinococcus multilocularis epidermal growth factor receptor 0.0097 0.0165 0.0165
Brugia malayi Furin-like cysteine rich region family protein 0.018 0.0413 0.0413
Schistosoma mansoni tyrosine kinase 0.0096 0.0162 0.0162
Toxoplasma gondii prostaglandin-E synthase 0.2648 0.7754 0.7746
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0123 0.0245 0.0484

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 3 nM Inhibition of partially purified EGFR tyrosine kinase from human A431 cells ChEMBL. 17869510

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.